143 related articles for article (PubMed ID: 166154)
1. Cyclic nucleotide phosphodiesterases: properties, activators, inhibitors, structure--activity relationships, and possible role in drug development.
Samir Amer M; Kreighbaum WE
J Pharm Sci; 1975 Jan; 64(1):1-37. PubMed ID: 166154
[No Abstract] [Full Text] [Related]
2. Inhibitory and activators of cyclic nucleotide phosphodiesterase.
Chasin M; Harris DN
Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316
[No Abstract] [Full Text] [Related]
3. Cyclic nucleotide phosphodiesterases.
Appleman MM; Thompson WJ; Russell TR
Adv Cyclic Nucleotide Res; 1973; 3():65-98. PubMed ID: 4361529
[No Abstract] [Full Text] [Related]
4. Rat adrenal cyclic nucleotide-phosphodiesterase; inhibition by drugs known to affect steroidogenesis.
Klotz U; Vapaatalo H; Stock K
Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(4):376-85. PubMed ID: 4340534
[No Abstract] [Full Text] [Related]
5. Rat diaphragm cyclic nucleotide-phosphodiesterase: influence of drugs affecting skeletal muscle contractility.
Klotz U; Vapaatalo H
Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(4):373-82. PubMed ID: 4375256
[No Abstract] [Full Text] [Related]
6. Phosphodiesterases from porcine coronary arteries: inhibition of separated forms by xanthines, papaverine, and cyclic nucleotides.
Wells JN; Wu YJ; Baird CE; Hardman JG
Mol Pharmacol; 1975 Nov; 11(6):775-83. PubMed ID: 173982
[No Abstract] [Full Text] [Related]
7. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
Goff AK; Major PW
FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943
[No Abstract] [Full Text] [Related]
8. Effects of some isoquinoline compounds and certain derivatives on brain phosphodiesterase activity.
Furlanut M; Carpenedo F; Ferrari M
Biochem Pharmacol; 1973 Oct; 22(20):2642-4. PubMed ID: 4357892
[No Abstract] [Full Text] [Related]
9. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
Ho C; Teo TS; Desai R; Wang JH
Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of cyclic 3',5'-nucleotide phosphodiesterase from the brain of the Madagascar cockroach (Gromphadorhina portentosa).
Rojakovick AS; March RB
Comp Biochem Physiol B; 1974 Jan; 47(1):189-99. PubMed ID: 4359119
[No Abstract] [Full Text] [Related]
11. Purification and properties of a cyclic nucleotide phosphodiesterase from bovine heart.
Goren EN; Rosen OM
Arch Biochem Biophys; 1972 Nov; 153(1):384-97. PubMed ID: 4346637
[No Abstract] [Full Text] [Related]
12. Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase.
Weiss B
Adv Cyclic Nucleotide Res; 1975; 5():195-211. PubMed ID: 165666
[TBL] [Abstract][Full Text] [Related]
13. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
Hidaka H; Asano T; Shimamoto T
Biochim Biophys Acta; 1975 Jan; 377(1):103-16. PubMed ID: 164219
[TBL] [Abstract][Full Text] [Related]
14. The adnosine 3',5'-monophosphate and guanosine 3',5'-monophosphate phosphodiesterases from human lung tissue.
Green D; Guy G; Moore JB
Life Sci; 1977 Apr; 20(7):1157-62. PubMed ID: 191714
[No Abstract] [Full Text] [Related]
15. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
Hidaka H; Asano T
Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
[TBL] [Abstract][Full Text] [Related]
16. Cyclic nucleotide phosphodiesterase in silkworm: purification and properties.
Morishima I
Biochim Biophys Acta; 1974 Nov; 370(1):227-41. PubMed ID: 4371846
[No Abstract] [Full Text] [Related]
17. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases.
Donnelly TE
Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034
[No Abstract] [Full Text] [Related]
18. Cyclic nucleotide phosphodiesterase from Tetrahymena.
Ramanathan S; Chou SC
Comp Biochem Physiol B; 1973 Sep; 46(1):93-7. PubMed ID: 4355795
[No Abstract] [Full Text] [Related]
19. Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues.
Sheppard H; Wiggan G; Tsien WH
Adv Cyclic Nucleotide Res; 1972; 1():103-12. PubMed ID: 4354559
[No Abstract] [Full Text] [Related]
20. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
Du Moulin A; Schultz J
Experientia; 1975 Aug; 31(8):883-4. PubMed ID: 169139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
